Study for performance evaluation of the QIAstat-Dx® Meningitis/Encephalitis Panel in comparison with other chosen comparator methods.
This multicenter study aims to evaluate the performance of QIAstat-Dx Meningitis/Encephalitis (ME) Panel with another validated comparator method.
Study Type
OBSERVATIONAL
Enrollment
595
Qiagen
Manchester, United Kingdom
sensitivity
positive percentage agreement
Time frame: 6 weeks
specificity
negative percentage agreement
Time frame: 6 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.